Mild renal dysfunction associated with incident coronary artery disease in young males (from MELANY Study Investigators) I read the research report from Pereg et al. in the related issue of European Heart Journal. Some wrong statements changing the meaning of the results of the study drew my attention at the third paragraph on page 201.
(1) They have stated 'Of note, 31 subjects with CAD were in the fifth quintile (Table 2) '.
According to my opinion, true statement concordant with Table 2 should be such as 'Of note, 31 subjects with CAD were in the first quintile (Table 2) '.
(2) They have also stated 'When an age adjustment analysis was performed, we observed a significant and progressive increase in the risk of CAD as the estimated creatinin clearance decreased, and the risk for CAD was found to be significantly higher in the fifth compared with the first quintile (HR ¼ 4.77, 95% confidence interval 3.22-7.06, P , 0.001) ( Table 2) '.
According to my opinion, true statement concordant with Table 2 should be such as 'When an age adjustment analysis was performed, we observed a significant and progressive increase in the risk of CAD as the estimated creatinin clearance decreased, and the risk for CAD was found to be significantly higher in the first compared with the fifth quintile (HR ¼ 4.77, 95% confidence interval 3.22-7.06, P , 0.001) ( Table 2 , the first quintile should represent the participants with the lower creatinine clearance, in whom the number of cases with CAD was the highest (31). The fifth quintile should represent those with the highest creatinine clearance and the lowest incidence of CAD (eight cases). We acknowledge this editing error, but it should not change the main finding of our study, demonstrating the inverse association between the estimated creatinine clearance values and the risk for developing CAD in a large population-based cohort of young and healthy males with normal or mildly reduced renal function. Table 3 under the subheading 'Clinical implications and recommendations' is misleading. In the text part, the authors confirm that a superior effectiveness of MDCT compared with other modalities for diagnosing congenital or structural anomalies of the heart has not been demonstrated. However, as far as the detection of coronary artery disease (CAD) is concerned, the evidence supporting the use of MDCT is also low.
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The diagnostic accuracy of MDCT in CAD has thoroughly been tested predominantly in patients who do not need it, i.e. in those at high risk in whom it had already been decided to proceed to conventional coronary angiography (CCA). In these populations, diagnostic performance of the test, at least its negative predictive value, is good. 3 It should not be taken for granted that these favourable results apply to unselected or lower risk populations as well. 4 Most trials have been focusing on the accuracy of MDCT in imaging coronary arteries, but that is not what our patients are asking for. What they want is their symptoms to be alleviated or their survival to be improved. From a societal perspective, these goals should be achieved at a reasonable cost. 
